To hear about similar clinical trials, please enter your email below
Trial Title:
Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer
NCT ID:
NCT05845801
Condition:
PDAC - Pancreatic Ductal Adenocarcinoma
Study type:
Observational [Patient Registry]
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
Register
Description:
Prospective collection of epidemiological, clinical, and pathological data of patients
diagnosed with early-onset pancreatic cancer (EO-PDAC) - namely, individuals who have
received a diagnosis of pancreatic cancer before, or at, the age of 55 years old.
Summary:
The objective of the present registry is the creation of a prospective registry
collecting clinico-pathological and genomic data, along with survival outcomes, of
individuals diagnosed with PDAC at or before the age of 55 years old. This registry is
intended with the aim of using collected data for future clinical trials, both
prospective and retrospective.
Criteria for eligibility:
Study pop:
The target population is represented by individuals who have received a pathological
diagnosis of pancreatic cancer before the age of 55 years old (namely, EO-PDAC patients).
No subject will be financially compensated for their participation.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Age ≤55 years old at the time of diagnosis of pancreatic cancer
- Age ≥ 18 years
- Written informed consent obtained.
Exclusion Criteria:
- Any pancreatic neoplasm other than pancreatic cancer (e.g. cholangiocarcinoma,
ampullary cancer,duodenal cancer, non-invasive mucinous cystic neoplasm, pancreatic
intra-epithelial neoplasia 1 and 2, non-invasive intraductal papillary mucinous
neoplasm, serous cystic neoplasm, pseudo papillary solid tumor, neuroendocrine
tumor)
- Absence of informed consent.
- Age < 18 years or > 55 years old at the time of diagnosis of pancreatic cancer
Gender:
All
Minimum age:
18 Years
Maximum age:
55 Years
Locations:
Facility:
Name:
AOUI Verona
Address:
City:
Verona
Zip:
37134
Country:
Italy
Status:
Recruiting
Contact:
Last name:
Elisa Venturini
Phone:
0458124671
Email:
elisa.venturini@univr.it
Start date:
December 7, 2022
Completion date:
September 30, 2052
Lead sponsor:
Agency:
Azienda Ospedaliera Universitaria Integrata Verona
Agency class:
Other
Source:
Azienda Ospedaliera Universitaria Integrata Verona
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05845801
